Cytek Biosciences Inc (CTKB)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Cytek Biosciences Inc-Aktie (CTKB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.00% 45.60	41.46	57.48	51.50	46.62
Cost Of Revenue	2.04% 21.73	21.30	23.82	22.50	21.18
Gross Profit	18.41% 23.87	20.16	33.65	29.00	25.44
Operating Expenses	1.82% 34.49	35.13	30.67	33.25	33.96
Benefits Costs and Expenses	0.66% 52.38	52.72	47.15	51.34	53.80
Costs And Expenses	0.66% 52.38	52.72	47.15	51.34	53.80
Operating Income/Loss	29.06% -10.62	-14.97	2.986	-4.248	-8.527
Nonoperating Income/Loss	3.77% 3.849	3.709	7.337	4.405	1.341
Income/Loss From Continuing Operations Before Tax	39.86% -6.775	-11.27	10.32	0.157	-7.186
Income Tax Expense/Benefit, Deferred	511.90% -2.056	-0.336	-	-	-
Income Tax Expense/Benefit	976.47% -1.192	0.136	0.68	-0.784	3.248
Income/Loss From Continuing Operations After Tax	51.03% -5.583	-11.40	9.643	0.941	-10.43
Net Income/Loss	51.03% -5.583	-11.40	9.643	0.941	-10.43
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1.09% 126.93	128.34	-0.51	131.00	131.44
Diluted Average Shares	1.09% 126.93	128.34	-0.51	132.79	131.44
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

PODD

$318.77

1.84%

STE

$237.32

0.69%

DXCM

$60.43

3.80%

PHG

$27.21

0.40%

GEHC

$74.47

0.64%

$83.07

0.75%